Tajik Migrant Health Education Study
MASLIHAT Intervention for Tajik Male Migrants Who Inject Drugs
2 other identifiers
interventional
420
1 country
1
Brief Summary
This study will test the efficacy of a peer-education prevention intervention to reduce risky drug, alcohol, and sexual behaviors among male Tajik labor migrants who inject drugs (MWID) while working in Moscow. The peer educator intervention will be compared to a health education control intervention. Each intervention consists of 5 weekly 2-hour small group sessions. Follow-up assessments will be conducted at 3, 6, 9, and 12 months after the intervention. It is hypothesized that, compared to MWID who receive the health education control intervention, those who receive the peer educator intervention will have a greater reduction in the frequency of risk behaviors. Similar effects are expected for network members of intervention participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv-infections
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2021
CompletedFirst Posted
Study publicly available on registry
April 21, 2021
CompletedStudy Start
First participant enrolled
October 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2023
CompletedResults Posted
Study results publicly available
December 6, 2024
CompletedDecember 6, 2024
December 1, 2024
1.5 years
April 16, 2021
November 7, 2024
December 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Syringe Sharing
injected with a previously used syringe
3 months
Sex Without Condom
vaginal or anal sex without a condom in the past 3 months
3 months
Alcohol Use
Number of days drinking alcohol in past month
30 days
Secondary Outcomes (2)
HIV Infection
12 months
Hepatitis C Infection
12 months
Other Outcomes (1)
Injection Equipment Sharing
3 months
Study Arms (2)
MASLIHAT peer education
EXPERIMENTALA peer educator prevention intervention program consisting of five weekly 2-hour small group sessions.
TANSIHAT health education
SHAM COMPARATORA health education program consisting of five weekly 2-hour sessions small group sessions.
Interventions
Eligibility Criteria
You may qualify if:
- adult Tajik man
- injected drugs in past 30 days
- living and working as migrant laborer in Moscow
You may not qualify if:
- does not intend to stay in Moscow for the next 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Illinois at Chicagolead
- National Institute on Drug Abuse (NIDA)collaborator
- Prisma Research Centercollaborator
Study Sites (1)
PRISMA Research Center
Moscow, Russia
Related Publications (5)
Mackesy-Amiti ME, Levy JA, Bahromov M, Jonbekov J, Luc CM. HIV and Hepatitis C Risk among Tajik Migrant Workers Who Inject Drugs in Moscow. Int J Environ Res Public Health. 2023 May 24;20(11):5937. doi: 10.3390/ijerph20115937.
PMID: 37297541BACKGROUNDLuc CM, Levy J, Bahromov M, Jonbekov J, Mackesy-Amiti ME. HIV knowledge, self-perception of HIV risk, and sexual risk behaviors among male Tajik labor migrants who inject drugs in Moscow. BMC Public Health. 2024 Jan 11;24(1):156. doi: 10.1186/s12889-023-17543-1.
PMID: 38212755BACKGROUNDMackesy-Amiti ME, Bahromov M, Levy JA, Jonbekov J, Luc CM. Changes in risk behaviour following a network peer education intervention for HIV prevention among male Tajik migrants who inject drugs in Moscow: a cluster-randomized controlled trial. J Int AIDS Soc. 2024 Jul;27 Suppl 3(Suppl 3):e26310. doi: 10.1002/jia2.26310.
PMID: 39030891RESULTMackesy-Amiti ME, Levy JA, Luc CM, Jonbekov J. Peer education intervention reduced sexually transmitted infections among male Tajik labor migrants who inject drugs: results of a cluster-randomized controlled trial. BMC Public Health. 2025 Jun 10;25(1):2154. doi: 10.1186/s12889-025-23387-8.
PMID: 40495129DERIVEDMackesy-Amiti ME, Levy JA, Luc CM, Jonbekov J. Peer Education Intervention Reduced Sexually Transmitted Infections Among Male Tajik Labor Migrants Who Inject Drugs: Results of a Cluster-randomized Controlled Trial. medRxiv [Preprint]. 2025 May 1:2024.08.15.24312070. doi: 10.1101/2024.08.15.24312070.
PMID: 39185538DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Mary E. Mackesy-Amiti
- Organization
- University of Illinois Chicago
Study Officials
- PRINCIPAL INVESTIGATOR
Mary E Mackesy-Amiti, Ph.D.
University of Illinois at Chicago
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate Professor
Study Record Dates
First Submitted
April 16, 2021
First Posted
April 21, 2021
Study Start
October 19, 2021
Primary Completion
May 4, 2023
Study Completion
May 28, 2023
Last Updated
December 6, 2024
Results First Posted
December 6, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- The data will be made available upon study completion.
- Access Criteria
- Access will be provided upon request with a description of the intended use.
The final data will be shared by depositing it in a public data repository. The final dataset will include self-reported sociodemographic characteristics, HIV transmission knowledge and risk awareness, sexual partners and risk behavior, illicit drug use and injection risk behavior, prevention self-efficacy, and injection drug use network interactions at 5 time points, and HIV and HCV test results at 2 time points. No identifying information will be included in the final dataset.